Download Citation
Article Source:
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
Thomenius MJ,
Totman J,
Harvey D,
Mitchell LH,
Riera TV,
et al.
(2018)
Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
PLOS ONE 13(6): e0197372.
https://doi.org/10.1371/journal.pone.0197372